Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesionsMutirangura, A; Sriuranpong, V; Termrunggraunglert, W; Tresukosol, D; Lertsaguansinchai, P; Voravud, N; Niruthisard, S · 1998

High prevalence of human papillomavirus type 58 in patients with cervical pre-malignant lesions in southern BrazilSuelen Paesi; Eduardo Pretto Serafini; Fernanda Barea; Sonia Regina Cabral Madi; Sergio Echeverrigaray · 2009

Evaluation of human papillomavirus 16 and 18 in premalignant and malignant cervical lesions by the polymerase chain reactionDe Santis, L.; Sestl, F.; Pasetto, N.; Piccione, E.; Novelli, G.; Dallapiccola, B. · Journal of Obstetrics and Gynaecology · 1992

Prevalence of human papillomavirus in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast BrazilJosé V Fernandes; Rosely V Meissner; Maria GF Carvalho; Thales AAM Fernandes; Paulo RM Azevedo; João S Sobrinho; José CM Prado; Luisa L Villa · 2010

p16^ink4a Is a Surrogate Marker for High-Risk and Malignant Cervical Lesions in the Presence of Human PapillomavirusLakshmi, S.; Rema, P.; Somanathan, Thara · Pathobiology · 2009

Association of Human Papillomavirus Type 16 E7 and HLA Class I Antigen Expression in Cervical Premalignant and Malignant LesionsWang, J.-F.; Wang, C.-X.; Wang, L.-S.; Zhang, J.; Yang, X.-J.; Liu, M.; Zheng, G.-X. · The International Journal of Biological Markers · 2007

Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesionsGhosh, Ishita; Muwonge, Richard; Mittal, Srabani; Banerjee, Dipanwita; Kundu, Pratip; Mandal, Ranajit; Biswas, Jaydip; Basu, Partha · Journal of Clinical Virology · 2017